Tag - medicine-4

 
 

MEDICINE 4

Japan Times
WORLD / Science & Health
Sep 20, 2019
U.S. scientists join effort to solve mysterious vaping-related illnesses
The U.S. investigation into hundreds of cases of life-threatening lung illnesses related to vaping has turned up a curious abnormality: Many of the victims had pockets of oil clogging up cells responsible for removing impurities in the lungs.
Japan Times
WORLD / Science & Health
Sep 18, 2019
Efforts against pandemics that could kill tens of millions 'grossly insufficient,' WHO and World Bank report says
The world faces a mounting threat of pandemics that could kill millions and wreak economic havoc, a international expert panel warns, saying governments should work to mitigate that risk.
Japan Times
JAPAN
Sep 15, 2019
Japan Medical Association to send senior official to North Korea to assess possibility of providing aid
The Japan Medical Association will send a senior official to North Korea in late September with an eye to providing medical aid in the future, an association source has said.
Japan Times
BUSINESS
Sep 12, 2019
Purdue Pharma reaches tentative opioid settlement in deal worth up to $12 billion, will file for bankruptcy soon: sources
OxyContin maker Purdue Pharma LP reached a tentative agreement with some plaintiffs to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing its settlement offer in bankruptcy proceedings starting as soon as next week, people familiar...
Japan Times
JAPAN
Sep 10, 2019
Japan needs to improve medical care for detainees, immigration chief says
There is a need to improve medical care at immigration detention centers, the head of the country's recently created Immigration Services Agency has said, following widespread criticism of the care available to detainees.
Japan Times
COMMENTARY / Japan
Sep 4, 2019
How to stop deadly outbreaks of diseases like Ebola — before they occur
Five years ago, an Ebola outbreak ripped through West Africa, killing over 11,000 people. During the 2014 outbreak, no effective vaccines or treatments were available while the international community's response was often perceived as too reactive.
Japan Times
BUSINESS / Companies
Sep 4, 2019
OxyContin maker Purdue prepares 'free-fall' bankruptcy as settlement talks stall, sources say
OxyContin maker Purdue Pharma LP is preparing to seek bankruptcy protection before the end of the month if it does not reach a settlement with U.S. communities over widespread opioid litigation, three people familiar with the matter said, after some states balked at the company's $10 billion to $12 billion...
Japan Times
WORLD / Science & Health
Sep 3, 2019
Cancer overtakes heart disease as biggest rich-world killer
Cancer has overtaken heart disease as the leading cause of death in wealthy countries and could become the world's biggest killer within just a few decades if current trends persist, researchers said on Tuesday.
JAPAN / Science & Health
Aug 29, 2019
Diagnosed HIV and AIDS infections down for second straight year in Japan
The combined number of people found to be infected with HIV or diagnosed with AIDS in Japan fell for the second straight year in 2018, the health ministry said Thursday.
Japan Times
WORLD / Science & Health
Aug 29, 2019
Measles cases worldwide have tripled this year, WHO says
Every region in the world, except the Americas, is experiencing an increase in the number of cases of measles, a vaccine-preventable disease that can kill or disable children, the World Health Organization said on Thursday.
Japan Times
JAPAN / Science & Health
Aug 29, 2019
Japan insurance council greenlights coverage for gene therapy drug to combat clogged arteries
The Central Social Insurance Medical Council on Wednesday approved the first health insurance system coverage for a gene therapy drug.
Japan Times
BUSINESS / Companies
Aug 28, 2019
Purdue Pharma discussing up to $12 billion offer to settle over 2,000 opioid claims and filing for bankruptcy
OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion, two people familiar with the matter said on Tuesday.
Japan Times
WORLD / Science & Health
Aug 27, 2019
U.S. opioid ruling gives 'green light' for other lawsuits
While some Johnson & Johnson investors were relieved that the company's $572 million penalty for fueling Oklahoma's opioid epidemic wasn't as high as feared, lawyers for other U.S. states, cities and counties could hardly contain their glee.
Japan Times
JAPAN
Aug 23, 2019
Japan's health insurance federation proposes excluding some hay fever drugs from public medical coverage
The proposal would end coverage for prescription and nonprescription drugs with identical ingredients, saving u00a560 billion a year but forcing patients to pay the full cost.
Japan Times
JAPAN
Aug 19, 2019
For Japan's medical interpretation industry, tourism boom presents growing challenge
During one of her medical-interpreting lessons in July, teacher Yoshiko Ishizaka, 77, brought up the case of a former student who was dealing with schizophrenia.
Japan Times
JAPAN / Media / BIG IN JAPAN
Aug 17, 2019
Dissecting the benefits of medical intervention in Japan
"Lies!" "Nonsense!"
Japan Times
BUSINESS / Companies
Aug 14, 2019
Japan drugstore giants Cocokara and Matsumotokiyoshi in merger talks
Major drugstore chain Cocokara Fine Inc. said Wednesday it will enter merger negotiations with industry peer Matsumotokiyoshi Holdings Co.
Japan Times
COMMENTARY / World
Aug 10, 2019
No one understands Lyme disease
The sooner experts admit it, the sooner we'll figure out what's happening and perhaps prevent a lot of suffering.
Japan Times
JAPAN / Science & Health
Aug 8, 2019
Japan's National Cancer Center releases survival rates for group of less common cancers
The center calculated the survival rates based on information gathered in 2012 from some 550,000 people who were diagnosed with cancer at 349 core hospitals.
Japan Times
BUSINESS
Aug 8, 2019
Novartis says it knew of Zolgensma data problems before U.S. approval
Swiss Drugmaker Novartis AG on Wednesday said it knew about discrepancies in data it submitted to regulators as it sought approval of its more than $2 million gene therapy Zolgensma, but delayed notifying authorities until it completed an internal investigation.

Longform

Traditional folk rituals like Mizudome-no-mai (dance to stop the rain) provide a sense of agency to a population that feels largely powerless in the face of the climate crisis.
As climate extremes intensify, Japan embraces ancient weather rituals